Kite Pharma, Inc. (NASDAQ:KITE) announced presentations on the Company’s rapid, six-day manufacturing process for the production of Kite’s lead product candidate, KTE-C19. Kite Pharma, Inc. (NASDAQ:KITE) belongs to Healthcare sector. Its weekly performance is -9.95%. On last trading day company shares ended up $74.16. Kite Pharma, Inc. (NASDAQ:KITE) distance from 50-day simple moving average (SMA50) is 38.61%. In a surprise move, Target Corp. (NYSE:TGT) has … Continue reading Notable Moves: Kite Pharma, Inc. (NASDAQ:KITE), Target Corp. (NYSE:TGT), Washington Federal Inc. (NASDAQ:WAFD), Cree, Inc. (NASDAQ:CREE), J C Penney Company Inc (NYSE:JCP)